Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ANN ARBOR, Mich., Feb. 19 /PRNewswire/ -- Compendia Bioscience, Inc. today announced results of a second productive year, including a renewed and expanding commitment from all major customers and the addition of several "Top 20" oncology drug companies to its customer roster. The new customers and existing customer commitment expansions led to a greater than 300% revenue increase, with similar growth forecasted for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

A key factor in Compendia's financial growth in 2007 was the mid-year release of Oncomine(TM) Concepts Edition, a unique analysis approach using drug and pathway signatures to help drug researchers and developers better understand a specific drug's biology and predict tumor populations likely to respond to the drug. Additionally, Compendia significantly expanded the Oncomine gene expression database in 2007 with cell line panels and drug perturbation studies, areas of specific interest for its customers.

"The addition of Oncomine Concepts Edition and targeted expansion of our data collection and curation efforts were key to our sales success last year, and multi-year commitments from customers have positioned us well for 2008 and beyond," said John Freshley, Compendia's Chief Business Officer. "We are particularly proud that we now count 12 of the top 20 oncology companies as our customers and are in active discussions with several more."

In addition, a major product milestone was completed in 2007 with the transition of the free academic offering from the University of Michigan to Compendia. With more than 15,000 user registrations, Oncomine has long been a leading tool for academic and non-profit researchers.

"This was a very significant step for Compendia," commented co-founder and CEO Dan Rhodes. "We have actively developed exciting new features for Oncomi
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... patients in Finland have gained access to more ... technology from Varian Medical Systems (NYSE: ... in the Nordic region. Clinicians at Docrates Clinic ... form of radiotherapy to treat patients with multiple ... prostate. ,, RapidArc, which enables clinicians to deliver ...
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), ... announced today that the first CyberKnife® Robotic Radiosurgery ... University Hospital of Liege. ,, The University ... of the largest hospitals in Euregio, a cross-country ... a full range of cancer treatments, University Hospital ...
(Date:12/14/2009)... Travelers of Interstate 70 west of Indianapolis ... bit more colorful when 10 multicolored art forms are ... going home , will eventually include 34 total ... student at Herron School of Art and Design, through ... ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 1What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 2What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 3What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 4What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 5EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 1EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 2EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 3Re Envision Your Look 3A Dr David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures 54137 1Re Envision Your Look 3A Dr David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures 54137 2Re Envision Your Look 3A Dr David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures 54137 3
... Meeting of the American,Psychiatric Association -, SAN ... adults with,major depressive disorder, adding aripiprazole to ... the primary,endpoint, the Montgomery- Asberg Depression Rating ... placebo-controlled study,presented here at the 160th Annual ...
... -- Asenapine -- an,investigational drug being developed by ... for bipolar I disorder and,schizophrenia -- was demonstrated ... manic and mixed episodes associated with bipolar,I disorder, ... study,presented at the American Psychiatric Association's 2007 Annual,Meeting. ...
Other Medicine Technology:Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4
(Date:12/15/2009)... Starting January 1, 2010 Oregon will require that certain businesses ... automated external defibrillator (AED) readily available. Fire and rescue ... an AED is a good investment. , ... ... January 1, 2010 Oregon will require that certain businesses with ...
(Date:12/15/2009)... San Diego Hospice and The Institute for Palliative Medicine ... 14, 2009. Mr. Price has been known for his ... business, community and personal life. Mr. Price was a ... of philanthropy and the role it plays in the ... countless philanthropic efforts. We extend our condolences to the ...
(Date:12/15/2009)... Dec. 15, 2009 UT Southwestern Medical Center ... date of the unique observable characteristics seen in ... , The findings, reported online and in the ... Endocrinology and Metabolism, suggest that patients with ... together with those diagnosed with two similar but ...
(Date:12/14/2009)... synthetic red-blood-cell-like particles carry oxygen, drugs, and more… , ... ... at UC Santa Barbara, in collaboration with scientists at University ... characteristics and key functions of natural red blood cells, including ... , , , ,The primary function of natural red blood ...
(Date:12/14/2009)... PARK, Ill. and HOLLYWOOD, Fla., Dec. 14 ... ) announced today a definitive agreement to ... ), a leading provider of laboratory information ... cash. ,, The acquisition strengthens Abbott,s ... providing advanced web-based applications to help laboratories ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4
... Centers for Disease,Control and Prevention (CDC), with ... Infection Control and Epidemiology (APIC), is,developing a ... data from existing commercial,software systems to the ... solution enables hospitals to provide data already,collected ...
... WASHINGTON, Dec. 13 "The American Veteran,",a monthly half-hour ... a full third of it,s January edition on two ... -- traumatic brain injury (TBI),and post traumatic stress disorder ... military personnel about,the VA programs and staff dedicated to ...
... Offering to Healthcare Customers, DALLAS, Dec. 13 ... of electronic transaction services to the,Healthcare industry, announced ... acquire substantially all the assets of Acceptius, Inc., ... to due diligence and is structured,as an asset ...
... ALPHARETTA, Ga., Dec. 13 MQ Associates, Inc. ... wholly owned,subsidiary of MQ Associates ("MedQuest"), announced today ... to purchase (i) any and all of the,outstanding ... 12 1/4%,Senior Discount Notes due 2012 (CUSIP No. ...
... Dec. 13 If Congress passes,legislation to give the ... products, the new law would save the state $449.8,million ... from,becoming new smokers, according to a new report released ... is a cosponsor of the,legislation. Senator Charles Grassley is ...
... marked cut-off for fertility, researchers say , THURSDAY, Dec. 13 ... chimpanzees go through menopause in the way that human females ... taper off at a similar age. , "When we look ... be reproducing better than humans in their forties," researcher Melissa ...
Other Medicine News:Health News:CDC Uses New Technical Approach to Enable Hospital Reporting of Healthcare-Associated Infections 2Health News:'The American Veteran' Targets TBI and PTSD 2Health News:'The American Veteran' Targets TBI and PTSD 3Health News:Claimsnet to Acquire Acceptius 2Health News:MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.'s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1) 2Health News:MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.'s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1) 3Health News:New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking 2Health News:New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking 3Health News:Menopause May Be Unique to Humans 2
...
...
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
Medicine Products: